BamSEC and AlphaSense Join Forces
Learn More

Heron Therapeutics Inc.

NASDAQ: HRTX    
Share price (8/18/25): $1.30    
Market cap (8/18/25): $199 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.5
from 8-K 79 pages Securities Purchase Agreement
12/34/56
EX-10.4
from 8-K 79 pages Note Purchase Agreement
12/34/56
EX-10.3
from 8-K 28 pages Heron Therapeutics, Inc. Exchange Agreement August 8, 2025
12/34/56
EX-10.2
from 8-K 73 pages Certain Information Has Been Omitted in Accordance With Item 601(b)(10) of Regulation S-K Because It Is Both Not Material and Is the Type of Information That the Registrant Treats as Private or Confidential. Omissions Are Marked [***]
12/34/56
EX-10.1
from 8-K 16 pages Cooperation Agreement
12/34/56
EX-10.4
from 10-Q 3 pages Amendment No. 5 to Co-Promotion Agreement
12/34/56
EX-10.3
from 10-Q 11 pages Heron Therapeutics, Inc. Management Retention Agreement
12/34/56
EX-10.2
from 10-Q 4 pages Amendment No. 4 to Co-Promotion Agreement
12/34/56
EX-10.1
from 10-Q 6 pages Amendment No.3 to Co-Promotion Agreement
12/34/56
EX-10.6
from 10-K 43 pages Agreement of Sublease
12/34/56
EX-10.5
from 10-K 12 pages Indemnification Agreement
12/34/56
EX-10.4
from 10-K 10 pages Heron Therapeutics, Inc. Amended and Restated 2007 Equity Incentive Plan Notice of Restricted Stock Unit Grant
12/34/56
EX-10.3
from 10-K 12 pages Heron Therapeutics, Inc. Amended and Restated 2007 Equity Incentive Plan Notice of Stock Option Grant
12/34/56
EX-10.1
from 8-K 11 pages First Amendment to Working Capital Facility Agreement
12/34/56
EX-10.2
from 10-Q 4 pages Certain Information Has Been Omitted in Accordance With Item 601(b)(10) of Regulation S-K Because It Is Both Not Material and Is the Type of Information That the Registrant Treats as Private or Confidential. Omissions Are Marked [***]. Amendment No.2 to Co-Promotion Agreement
12/34/56
EX-10.1
from 10-Q 5 pages Certain Information Has Been Omitted in Accordance With Item 601(b)(10) of Regulation S-K Because It Is Both Not Material and Is the Type of Information That the Registrant Treats as Private or Confidential. Omissions Are Marked [***]. Amendment No.1 to Co-Promotion Agreement
12/34/56
EX-10.1
from 10-Q 26 pages Certain Information Has Been Omitted in Accordance With Item 601(b)(10) of Regulation S-K Because It Is Both Not Material and Is the Type of Information That the Registrant Treats as Private or Confidential. Omissions Are Marked [***]. Co-Promotion Agreement
12/34/56
EX-10.10
from 10-Q 59 pages Agreement
12/34/56
EX-10.4
from 10-Q 10 pages Heron Therapeutics, Inc. Management Retention Agreement
12/34/56
EX-10.3
from 10-Q 10 pages Heron Therapeutics, Inc. Management Retention Agreement
12/34/56